Clinical Trial Update: Intracoronary Adenosine Administration to Prevent Periprocedural Myonecrosis in Elective Coronary Angioplasty [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated intracoronary adenosine to prevent periprocedural myonecrosis during elective coronary angioplasty; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Adenosine (Adenosine)

Snippet

Sponsor: Azienda Ospedaliero Universitaria Maggiore della Carita | Conditions: Coronary Angioplasty | Phase 3 | Status: COMPLETED